tiprankstipranks
Neuren Pharmaceuticals Limited (NURPF)
OTHER OTC:NURPF

Neuren Pharmaceuticals Limited (NURPF) Stock News & Sentiment

25 Followers
Neuren Pharmaceuticals Seeks New Security Quotation
PremiumCompany Announcements
Neuren Pharmaceuticals Seeks New Security Quotation
8d ago
Australian Stocks: Neuren’s (NEU) Daybue Sales Fail to Impress, Shares Plunge
PremiumGlobal Markets
Australian Stocks: Neuren’s (NEU) Daybue Sales Fail to Impress, Shares Plunge
2M ago
Neuren (NEU) Shares Plunge as Short Seller Targets Partner Acadia
PremiumGlobal Markets
Neuren (NEU) Shares Plunge as Short Seller Targets Partner Acadia
2M ago

News Score - Last 7 Days

Neutral
NURPF
Sector Average
Media Buzz
This Week1 articles
Weekly Average1.5 articles
News Sentiment
This Week50%
Sector Average64%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NURPF’s Media Buzz Sentiment?
1 articles about NURPF were published this week. In an average week, 1.5 articles are published.
    What is NURPF’s weekly average amount of articles?
    In an average week, 1.5 articles about NURPF are published.
      What is NURPF’s News Sentiment?
      50% of articles about NURPF were positive this week, compared to its sector average of 64%.
        Healthcare Stocks that are Trending in the News
        0HNZFagron SA
        ALPNAlpine Immune Sciences
        JANXJanux Therapeutics Inc
        SIGASIGA Technologies
        INNMFAmplia Therapeutics Ltd.
        Showing the stocks with the most bullish news sentiment over the past week
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis